These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 1984676)

  • 1. Circulating hyaluronan in the myelofibrosis/osteomyelosclerosis syndrome and other myeloproliferative disorders.
    Hasselbalch H; Junker P; Lisse I; Lindqvist U; Engström Laurent A
    Am J Hematol; 1991 Jan; 36(1):1-8. PubMed ID: 1984676
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Procollagen type III aminoterminal peptide in serum in idiopathic myelofibrosis and allied conditions: relation to disease activity and effect of chemotherapy.
    Hasselbalch H; Junker P; Hørslev-Petersen K; Lisse I; Bentsen KD
    Am J Hematol; 1990 Jan; 33(1):18-26. PubMed ID: 2293759
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Levels of procollagen type III n-terminal peptide (PIIINP) in serum of patients with myeloproliferative syndrome (mps)].
    Podolak-Dawidziak M; Wróbel T; Jeleń M
    Pol Arch Med Wewn; 1998 Jan; 99(1):24-9. PubMed ID: 9686500
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum procollagen III peptide in chronic myeloproliferative disorders.
    Hasselbalch H; Junker P; Lisse I; Bentsen KD
    Scand J Haematol; 1985 Nov; 35(5):550-7. PubMed ID: 4089533
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum laminin P1 in idiopathic myelofibrosis and related diseases.
    Hasselbalch H; Junker P
    Leuk Res; 1994 Aug; 18(8):623-8. PubMed ID: 8065164
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum markers for type IV collagen and type III procollagen in the myelofibrosis-osteomyelosclerosis syndrome and other chronic myeloproliferative disorders.
    Hasselbalch H; Junker P; Lisse I; Bentsen KD; Risteli L; Risteli J
    Am J Hematol; 1986 Oct; 23(2):101-11. PubMed ID: 3752065
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Collagen metabolism and enzymes of the urokinase plasminogen activator system in chronic myeloproliferative disorders: correlation between plasma-soluble urokinase plasminogen activator receptor and serum markers for collagen metabolism.
    Jensen MK; Riisbro R; Holten-Andersen MN; Brown Pde N; Junker P; Brünner N; Hasselbalch HC
    Eur J Haematol; 2003 Oct; 71(4):276-82. PubMed ID: 12950237
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Aminoterminal propeptide of type III procollagen and hyaluronan in patients with primary biliary cirrhosis: markers of fibrosis in primary biliary cirrhosis.
    Remmel T; Remmel H; Salupere V
    J Gastroenterol Hepatol; 1996 Nov; 11(11):1016-20. PubMed ID: 8985819
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Monitoring of multiple myeloma and bone marrow fibrosis with aminoterminal propeptide of type III collagen (PIIINP).
    Taube T; Franssila K; Risteli L; Risteli J; Elomaa I
    Br J Haematol; 1992 Sep; 82(1):32-7. PubMed ID: 1419800
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum levels of aminoterminal type III procollagen peptide and hyaluronan predict mortality in systemic sclerosis.
    Scheja A; Akesson A; Hørslev-Petersen K
    Scand J Rheumatol; 1992; 21(1):5-9. PubMed ID: 1570489
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Different effects of thyroid disease on serum levels of procollagen III N-peptide and hyaluronic acid.
    Faber J; Hørslev-Petersen K; Perrild H; Lorenzen I
    J Clin Endocrinol Metab; 1990 Oct; 71(4):1016-21. PubMed ID: 2401705
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum type-III-procollagen and laminin concentration after interferon therapy in chronic myeloproliferative disorders.
    Sréter L; Kárteszi M; Fehér J; Lutz D
    Acta Med Hung; 1988; 45(3-4):323-8. PubMed ID: 3249659
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increased serum procollagen III aminoterminal peptide in myelofibrosis.
    Hochweiss S; Fruchtman S; Hahn EG; Gilbert H; Donovan PB; Johnson J; Goldberg JD; Berk PD
    Am J Hematol; 1983 Dec; 15(4):343-51. PubMed ID: 6650494
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum hyaluronan and aminoterminal propeptide of type III procollagen in primary biliary cirrhosis: relation to clinical symptoms, liver histopathology and outcome.
    Nyberg A; Lindqvist U; Engström-Laurent A
    J Intern Med; 1992 May; 231(5):485-91. PubMed ID: 1602286
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bone marrow fibrosis and disease activity in multiple myeloma monitored by the aminoterminal propeptide of procollagen III in serum.
    Abildgaard N; Bendix-Hansen K; Kristensen JE; Vejlgaard T; Risteli L; Nielsen JL; Heickendorff L
    Br J Haematol; 1997 Dec; 99(3):641-8. PubMed ID: 9401078
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Development of polycythemia to myelofibrosis. Monitoring by the assay of the procollagen III amino-propeptide].
    Arrago JP; Poirier O; Najean Y
    Presse Med; 1984 Nov; 13(40):2429-32. PubMed ID: 6239221
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Matrix metalloproteinases, tissue inhibitors of metalloproteinases, aminoterminal propeptide of procollagen type III, and hyaluronan in sera and tissue of patients with capsular contracture after augmentation with Trilucent breast implants.
    Ulrich D; Lichtenegger F; Eblenkamp M; Repper D; Pallua N
    Plast Reconstr Surg; 2004 Jul; 114(1):229-36. PubMed ID: 15220598
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hepatic and renal extraction of circulating type III procollagen amino-terminal propeptide and hyaluronan in pig.
    Bentsen KD; Henriksen JH; Boesby S; Hørslev-Petersen K; Lorenzen I
    J Hepatol; 1989 Sep; 9(2):177-83. PubMed ID: 2809157
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Type III aminoterminal propeptide of procollagen in some haematological malignancies.
    Arrago JP; Poirier O; Chomienne C; D'Agay MF; Najean Y
    Scand J Haematol; 1986 Mar; 36(3):288-94. PubMed ID: 3704553
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synovial fluid and serum concentrations of aminoterminal propeptide of type III procollagen in healthy volunteers and patients with joint disease.
    Sharif M; George E; Dieppe PA
    Ann Rheum Dis; 1996 Jan; 55(1):47-51. PubMed ID: 8572734
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.